Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in REGENERON PHARMACEUTICALS
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 723,621 shares of REGN (REGENERON PHARMACEUTICALS), worth $559.1M as of 2026-Q1. The position was decreased (-2.9% shares). REGN represents 0.1% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$559.1M
Current Shares
723,621
Total Value Change
-$331.8M
Total Shares Change
-124,061
Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 723,621 |
-2.9% |
| $559.1M |
| 0.1% |
| $766.66 |
0 |
| 2025-Q4 | Increased | 745,233 | +0.1% | $575.2M | 0.1% | $773.94 | 38 |
| 2025-Q3 | Decreased | 744,173 | -13.5% | $418.4M | 0.1% | $560.05 | 0 |
| 2025-Q2 | Decreased | 860,441 | -8.5% | $451.7M | 0.1% | $519.56 | 0 |
| 2025-Q1 | Decreased | 940,336 | -4.3% | $596.4M | 0.2% | $634.66 | 0 |
| 2024-Q4 | Increased | 982,064 | +30.1% | $699.6M | 0.2% | $698.71 | 48 |
| 2024-Q3 | Decreased | 755,112 | -10.9% | $793.8M | 0.2% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 847,682 | +23.8% | $890.9M | 0.3% | $1,045.23 | 46 |